A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia

Leukemia

Volumn 11, Issue 1, 1997, Pages 48-53

  Hedley, D W ^a   Xie, S Xiu Yan ^a   Minden, M D ^a   Choi, C H ^a,b   Chen, H ^a,c   Ling, V ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b Chosun University   (South Korea)

^c NPS Allelix Corp   (Canada)

^d BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

ABC transporter; Drug resistance; Leukemia; MRP; P glycoprotein

Indexed keywords

2,4 DINITROPHENOL; ABC TRANSPORTER; AZIDE; CYANIDE; CYCLOSPORIN A; DAUNORUBICIN; GLYCOPROTEIN P; MESSENGER RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TRANSPORT; ENERGY TRANSFER; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0031043515     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400538     Document Type: Article

References (23)

1. Childs S, Ling V. The MDR superfamily of genes and its biological implications. In: VT DeVita, S Hellman, SA Rosenberg (eds). Important Advances in Oncology. Lippincott: Philadelphia, 1994, pp 21-36.
2. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 1993; 62: 385-427.
3. Almquist KC, Loe DW, Hipfner DR, Mackie JE, Cole SPC, Deeley RC. Characterization of the Mr 19000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res 1995; 55: 102-110.
4. Cole SPC, Bhardwaj C, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650-1654.
5. Schuurhuis GJ, Broxterman HJ, Ossenkoppele GJ, Baak JPA, Eekman CA, Kuiper CM, Feller N, van Heijningen THM, Klumper E, Pieters R, Lankelma J, Pinedo HM. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-β-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia. Clin Cancer Res 1995; 1: 81-93.
6. Xie SX-Y, Robb D, Chow S, Hedley D. Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia. Leukemia 1995; 9: 1882-1887.
7. See YP, Carlsen SA, Till JE, Ling V. Increased drug permeability in Chinese hamster ovary cells in the presence of cyanide. Biochim Biophys Acta 1974; 373: 242-252.
8. Cole SP, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 1994; 54: 5902-5910.
9. Versantvoort CHM, Broxterman HJ, Lankelma J, Feller N, Pinedo HM. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol 1994; 48: 1129-1136.
10. Kartner N, Evernden-Porelle D, Bradley G, Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 1985; 316: 820-823.
11. Ishida Y, Ohtsu T, Hamada H, Sugimoto Y, Tobinai K, Minato K, Tsuruo T, Shimoyama M. Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16. Jap J Cancer Res 1989; 80: 1006-1013.
12. Cumber PM, Jacobs A, Hoy T, Whittaker JA, Tsuruo T, Padua RA. Increased drug accumulation ex vivo with cyclosporin in chronic lymphatic leukemia and its relationship to epitope masking of P-glycoprotein. Leukemia 1991; 5: 1050-1053.
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 1987; 162: 156-159.
14. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994; 54: 357-361.
15. Burger H, Nooter K, Zaman GJ, Sonneveld P, van Wingerden KE, Oostrum RG, Stotor G. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia 1994; 8: 990-997.
16. Simon S, Roy D, Schindler M. Intracellular pH and the control of multidrug resistance. Proc Natl Acad Sci USA 1994; 91: 1128-1132.
17. Roepe PD. Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cell expressing different levels of P-glycoprotein. Biochemistry 1992; 31: 12555-12564.
18. Boyer MJ, Hedley DW. Measurement of intracellular pH. In: Darzynkiewicz Z, Robinson JP, Crissman HA (eds). Methods in Cell Biology, Vol 41. Academic Press: San Diego, 1994, pp 135-148.
19. Leith CP, Chen I-M, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Wieck JK, Willman CL. Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/effux+ and MDR1+/efflux- cases. Blood 1995; 86: 2329-2342.
20. Maslak P, Hegewisch-Becker S, Godfrey L, Andreeff M. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia. Cytometry 1994; 17: 84-93.
21. Herweijer H, Sonneveld P, Baas F, Nooter K. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 1990; 82: 1133-1140.
22. Versantvoort CH, Broxterman HJ, Lankelma J, Feller N, Pinedo HM. Competitive inhibition by genistein and ATP dependence of daunorubucin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol 1994; 48: 1129-1136.
23. Holmes JA, West RR. The effect of MDR-1 gene expression on outcome in acute myeloid leukemia. Br J Cancer 1994; 69: 382-384.